Pharmacogenomics

An introduction to cost-effectiveness and cost–benefit analysis of pharmacogenomics
pp. 231-239(9)
Authors: Phillips, Kathryn A; Veenstra, David; Bebber, Stephanie Van; Sakowski, Julie

Bulletin Board
pp. 241-244(4)

Genomic & Proteomic Technological Advances in Cancer Research
pp. 245-249(5)
Author: Khan, Javed

Microarray Technologies 2003 - An Overview
pp. 251-256(6)
Author: Hardiman, Gary

Chemical genomics as an emerging paradigm for postgenomic drug discovery
pp. 257-267(11)
Author: Salemme, F Raymond

ER-α variants and the cardiovascular effects of hormone replacement therapy
pp. 269-277(9)
Authors: Herrington, David M; Howard, Tim D

Pharmacogenomics of primary hypertension – the lessons from the past to look toward the future
pp. 279-296(18)
Authors: Bianchi, Giuseppe; Staessen, Jan A; Patrizia, Ferrari

Genetic basis of psoriasis vulgaris and its pharmacogenetic potential
pp. 297-308(12)
Author: Ameen, Mahreen

Pharmacogenomic considerations for immunosuppressive therapy
pp. 309-319(11)
Authors: Yagil, Yoram; Yagil, Chana

Pharmacogenomics: implications and considerations for pharmacists
pp. 321-330(10)
Authors: Brock, Tina Penick; Valgus, John M; Smith, Scott R; Summers, Kelly M

Developmental and pediatric pharmacogenomics
pp. 331-341(11)
Author: Leeder, J Steven

Managing core resources for genomics and proteomics
pp. 343-350(8)
Authors: Apweiler, Rolf; Martin, Maria Jesus; O’Donovan, Claire; Pruess, Manuela

Etiologics Ltd
pp. 351-357(7)
Authors: Campbell, David A; Fitzgerald, Mary F